Amneal Pharmaceuticals, Inc. (AMRX)
Healthcare
Drug Manufacturers - Specialty & Generic
18.30 $
-1.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Amneal Pharmaceuticals, Inc. (AMRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 796 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 620 | 617 | 659 | 702 | 702 | 731 | 695 | 725 | 785 | 814 | 723 | 796 | 3,118 | |
| 388 | 392 | 421 | 452 | 433 | 468 | 440 | 438 | 511 | 517 | 402 | 462 | 1,892 | |
| 233 | 225 | 238 | 250 | 270 | 263 | 256 | 286 | 274 | 297 | 320 | 335 | 1,226 | |
| 42 | 47 | 39 | 37 | 61 | 56 | 42 | 50 | 63 | 35 | 38 | 39 | 176 | |
| 113 | 97 | 113 | 116 | 119 | 94 | 118 | 124 | 138 | 146 | 187 | – | – | |
| 157 | 211 | 249 | 154 | 181 | 187 | 156 | 175 | 274 | 183 | 187 | 188 | 831 | |
| 76 | 14 | -11 | 95 | 89 | 76 | 100 | 111 | -0.1 | 115 | 134 | 146 | 394 | |
| 51 | 60 | 66 | 66 | 66 | 62 | 57 | 65 | 63 | 56 | 53 | 55 | 227 | |
| 23 | -83 | -76 | 20 | 15 | -15 | 37 | 52 | -5.2 | 55 | 80 | 71 | 201 | |
| -2.1 | 9.9 | 6.2 | 3.6 | 3.7 | 5.4 | 13 | 16 | -23 | 5.7 | 2.2 | 1.4 | -14 | |
| 9.7 | -99 | -92 | 6.0 | -0.2 | -31 | 12 | 22 | 2.4 | 35 | 62 | 58 | 158 | |
| 131 | 33 | 46 | 142 | 140 | 112 | 155 | 177 | 112 | 161 | 177 | 194 | 643 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.